CIOMS Guidance for Medicines Safety
-
Chair(s):
Professor Hervé Le Louet,
President,CIOMS, Geneva, SwitzerlandProfessor Lembit Rago
Secretary General,CIOMS, Geneva, Switzerland -
Session description:
Quo vadis CIOMS?
Dr Lembit Rägo
Secretary General, CIOMS, Geneva, SwitzerlandPatient Involvement in Drug Development and Safe Use
Mr François Houÿez
Director of Treatment Informtion and Access, European Organisation for Rare Diseases, FranceSever Cutaneous Adverse Reactions (SCARS)
Professor Hervé Le Louet
President, CIOMS, Geneva, SwitzerlandDrug Induced Liver Injury (DILI)
Professor Raul Andrade
Secretary General, CIOMS, Geneva, SwitzerlandBenefit/ Risk Assessment During the life-cycle of Medicines
TBC
TBC
Speakers
-
Dr Lembit RägoSecretary General,CIOMS, Geneva, Switzerland
-
François HouÿezEURORDIS-Rare Diseases Europe
-
Professor Hervé Le LouetPast President of the International Society of Pharmacovigilance and European Medicines Agency
-
Professor Raul AndradeDepartment of Medicine, University of Málaga, Spain